Immunofluorescence Assay market worldwide is projected to grow by US$698. 9 Million, driven by a compounded growth of 5. 5%. Reagents, one of the segments analyzed and sized in this study, displays the potential to grow at over 6.

New York, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Immunofluorescence Assay Industry" - https://www.reportlinker.com/p05798812/?utm_source=GNW
1%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$1 Billion by the year 2025, Reagents will bring in healthy gains adding significant momentum to global growth.

- Representing the developed world, the United States will maintain a 6.3% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$32.2 Million to the region’s size and clout in the next 5 to 6 years. Over US$32.7 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Reagents will reach a market size of US$87.6 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 5.3% over the next couple of years and add approximately US$121.1 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include, among others, Abcam PLC; Bio-Rad Laboratories, Inc.; Cell Signaling Technology, Inc.; Danaher Corporation; INOVA Diagnostics, Inc.; Medipan GmbH; MilliporeSigma; PerkinElmer, Inc.; Sino Biological Inc.; Thermo Fisher Scientific, Inc.; Vector Laboratories, Inc.


Read the full report: https://www.reportlinker.com/p05798812/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Immunofluorescence Assay Competitor Market Share Scenario
Worldwide (in %): 2019 & 2025
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Immunofluorescence Assay Global Market Estimates and
Forecasts in US$ Thousand by Region/Country: 2018-2025
Table 2: Immunofluorescence Assay Global Retrospective Market
Scenario in US$ Thousand by Region/Country: 2009-2017
Table 3: Immunofluorescence Assay Market Share Shift across Key
Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Reagents (Product) World Market by Region/Country in
US$ Thousand: 2018 to 2025
Table 5: Reagents (Product) Historic Market Analysis by
Region/Country in US$ Thousand: 2009 to 2017
Table 6: Reagents (Product) Market Share Breakdown of Worldwide
Sales by Region/Country: 2009 VS 2019 VS 2025
Table 7: Instruments (Product) Potential Growth Markets
Worldwide in US$ Thousand: 2018 to 2025
Table 8: Instruments (Product) Historic Market Perspective by
Region/Country in US$ Thousand: 2009 to 2017
Table 9: Instruments (Product) Market Sales Breakdown by
Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 10: Antibodies (Product) Geographic Market Spread
Worldwide in US$ Thousand: 2018 to 2025
Table 11: Antibodies (Product) Region Wise Breakdown of Global
Historic Demand in US$ Thousand: 2009 to 2017
Table 12: Antibodies (Product) Market Share Distribution in
Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 13: Kits (Product) World Market Estimates and Forecasts
by Region/Country in US$ Thousand: 2018 to 2025
Table 14: Kits (Product) Market Historic Review by
Region/Country in US$ Thousand: 2009 to 2017
Table 15: Kits (Product) Market Share Breakdown by
Region/Country: 2009 VS 2019 VS 2025
Table 16: Consumables & Accessories (Product) World Market by
Region/Country in US$ Thousand: 2018 to 2025
Table 17: Consumables & Accessories (Product) Historic Market
Analysis by Region/Country in US$ Thousand: 2009 to 2017
Table 18: Consumables & Accessories (Product) Market Share
Distribution in Percentage by Region/Country: 2009 VS 2019 VS
2025
Table 19: Indirect Immunofluorescence (Type) World Market
Estimates and Forecasts in US$ Thousand by Region/Country: 2018
to 2025
Table 20: Indirect Immunofluorescence (Type) Market Worldwide
Historic Review by Region/Country in US$ Thousand: 2009 to 2017
Table 21: Indirect Immunofluorescence (Type) Market Percentage
Share Distribution by Region/Country: 2009 VS 2019 VS 2025
Table 22: Direct Immunofluorescence (Type) Market Opportunity
Analysis Worldwide in US$ Thousand by Region/Country: 2018 to
2025
Table 23: Direct Immunofluorescence (Type) Global Historic
Demand in US$ Thousand by Region/Country: 2009 to 2017
Table 24: Direct Immunofluorescence (Type) Market Share
Distribution in Percentage by Region/Country: 2009 VS 2019 VS
2025
Table 25: Cancer (Disease) World Market by Region/Country in
US$ Thousand: 2018 to 2025
Table 26: Cancer (Disease) Historic Market Analysis by
Region/Country in US$ Thousand: 2009 to 2017
Table 27: Cancer (Disease) Market Share Breakdown of Worldwide
Sales by Region/Country: 2009 VS 2019 VS 2025
Table 28: Infectious Diseases (Disease) Potential Growth
Markets Worldwide in US$ Thousand: 2018 to 2025
Table 29: Infectious Diseases (Disease) Historic Market
Perspective by Region/Country in US$ Thousand: 2009 to 2017
Table 30: Infectious Diseases (Disease) Market Sales Breakdown
by Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 31: Autoimmune Diseases (Disease) Geographic Market
Spread Worldwide in US$ Thousand: 2018 to 2025
Table 32: Autoimmune Diseases (Disease) Region Wise Breakdown
of Global Historic Demand in US$ Thousand: 2009 to 2017
Table 33: Autoimmune Diseases (Disease) Market Share
Distribution in Percentage by Region/Country: 2009 VS 2019 VS
2025
Table 34: Cardiovascular Diseases (Disease) World Market
Estimates and Forecasts by Region/Country in US$ Thousand: 2018
to 2025
Table 35: Cardiovascular Diseases (Disease) Market Historic
Review by Region/Country in US$ Thousand: 2009 to 2017
Table 36: Cardiovascular Diseases (Disease) Market Share
Breakdown by Region/Country: 2009 VS 2019 VS 2025
Table 37: Other Diseases (Disease) World Market by
Region/Country in US$ Thousand: 2018 to 2025
Table 38: Other Diseases (Disease) Historic Market Analysis by
Region/Country in US$ Thousand: 2009 to 2017
Table 39: Other Diseases (Disease) Market Share Distribution in
Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 40: Pharmaceutical & Biotechnology Companies (End-Use)
Global Opportunity Assessment in US$ Thousand by
Region/Country: 2018-2025
Table 41: Pharmaceutical & Biotechnology Companies (End-Use)
Historic Sales Analysis in US$ Thousand by Region/Country:
2009-2017
Table 42: Pharmaceutical & Biotechnology Companies (End-Use)
Percentage Share Breakdown of Global Sales by Region/Country:
2009 VS 2019 VS 2025
Table 43: Academic & Research Institutes (End-Use) Worldwide
Sales in US$ Thousand by Region/Country: 2018-2025
Table 44: Academic & Research Institutes (End-Use) Historic
Demand Patterns in US$ Thousand by Region/Country: 2009-2017
Table 45: Academic & Research Institutes (End-Use) Market Share
Shift across Key Geographies: 2009 VS 2019 VS 2025
Table 46: Hospitals & Diagnostic Centers (End-Use) Global
Market Estimates & Forecasts in US$ Thousand by Region/Country:
2018-2025
Table 47: Hospitals & Diagnostic Centers (End-Use)
Retrospective Demand Analysis in US$ Thousand by
Region/Country: 2009-2017
Table 48: Hospitals & Diagnostic Centers (End-Use) Market Share
Breakdown by Region/Country: 2009 VS 2019 VS 2025
Table 49: Contract Research Organizations (End-Use) Demand
Potential Worldwide in US$ Thousand by Region/Country:
2018-2025
Table 50: Contract Research Organizations (End-Use) Historic
Sales Analysis in US$ Thousand by Region/Country: 2009-2017
Table 51: Contract Research Organizations (End-Use) Share
Breakdown Review by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Immunofluorescence Assay Market Share (in %) by Company:
2019 & 2025
Table 52: United States Immunofluorescence Assay Market
Estimates and Projections in US$ Thousand by Product: 2018 to
2025
Table 53: Immunofluorescence Assay Market in the United States
by Product: A Historic Review in US$ Thousand for 2009-2017
Table 54: United States Immunofluorescence Assay Market Share
Breakdown by Product: 2009 VS 2019 VS 2025
Table 55: United States Immunofluorescence Assay Market
Estimates and Projections in US$ Thousand by Type: 2018 to 2025
Table 56: Immunofluorescence Assay Market in the United States
by Type: A Historic Review in US$ Thousand for 2009-2017
Table 57: United States Immunofluorescence Assay Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 58: United States Immunofluorescence Assay Market
Estimates and Projections in US$ Thousand by Disease: 2018 to
2025
Table 59: Immunofluorescence Assay Market in the United States
by Disease: A Historic Review in US$ Thousand for 2009-2017
Table 60: United States Immunofluorescence Assay Market Share
Breakdown by Disease: 2009 VS 2019 VS 2025
Table 61: United States Immunofluorescence Assay Latent Demand
Forecasts in US$ Thousand by End-Use: 2018 to 2025
Table 62: Immunofluorescence Assay Historic Demand Patterns in
the United States by End-Use in US$ Thousand for 2009-2017
Table 63: Immunofluorescence Assay Market Share Breakdown in
the United States by End-Use: 2009 VS 2019 VS 2025
CANADA
Table 64: Canadian Immunofluorescence Assay Market Estimates
and Forecasts in US$ Thousand by Product: 2018 to 2025
Table 65: Canadian Immunofluorescence Assay Historic Market
Review by Product in US$ Thousand: 2009-2017
Table 66: Immunofluorescence Assay Market in Canada: Percentage
Share Breakdown of Sales by Product for 2009, 2019, and 2025
Table 67: Canadian Immunofluorescence Assay Market Estimates
and Forecasts in US$ Thousand by Type: 2018 to 2025
Table 68: Canadian Immunofluorescence Assay Historic Market
Review by Type in US$ Thousand: 2009-2017
Table 69: Immunofluorescence Assay Market in Canada: Percentage
Share Breakdown of Sales by Type for 2009, 2019, and 2025
Table 70: Canadian Immunofluorescence Assay Market Estimates
and Forecasts in US$ Thousand by Disease: 2018 to 2025
Table 71: Canadian Immunofluorescence Assay Historic Market
Review by Disease in US$ Thousand: 2009-2017
Table 72: Immunofluorescence Assay Market in Canada: Percentage
Share Breakdown of Sales by Disease for 2009, 2019, and 2025
Table 73: Canadian Immunofluorescence Assay Market Quantitative
Demand Analysis in US$ Thousand by End-Use: 2018 to 2025
Table 74: Immunofluorescence Assay Market in Canada:
Summarization of Historic Demand Patterns in US$ Thousand by
End-Use for 2009-2017
Table 75: Canadian Immunofluorescence Assay Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
JAPAN
Table 76: Japanese Market for Immunofluorescence Assay: Annual
Sales Estimates and Projections in US$ Thousand by Product for
the Period 2018-2025
Table 77: Immunofluorescence Assay Market in Japan: Historic
Sales Analysis in US$ Thousand by Product for the Period
2009-2017
Table 78: Japanese Immunofluorescence Assay Market Share
Analysis by Product: 2009 VS 2019 VS 2025
Table 79: Japanese Market for Immunofluorescence Assay: Annual
Sales Estimates and Projections in US$ Thousand by Type for the
Period 2018-2025
Table 80: Immunofluorescence Assay Market in Japan: Historic
Sales Analysis in US$ Thousand by Type for the Period 2009-2017
Table 81: Japanese Immunofluorescence Assay Market Share
Analysis by Type: 2009 VS 2019 VS 2025
Table 82: Japanese Market for Immunofluorescence Assay: Annual
Sales Estimates and Projections in US$ Thousand by Disease for
the Period 2018-2025
Table 83: Immunofluorescence Assay Market in Japan: Historic
Sales Analysis in US$ Thousand by Disease for the Period
2009-2017
Table 84: Japanese Immunofluorescence Assay Market Share
Analysis by Disease: 2009 VS 2019 VS 2025
Table 85: Japanese Demand Estimates and Forecasts for
Immunofluorescence Assay in US$ Thousand by End-Use: 2018 to
2025
Table 86: Japanese Immunofluorescence Assay Market in US$
Thousand by End-Use: 2009-2017
Table 87: Immunofluorescence Assay Market Share Shift in Japan
by End-Use: 2009 VS 2019 VS 2025
CHINA
Table 88: Chinese Immunofluorescence Assay Market Growth
Prospects in US$ Thousand by Product for the Period 2018-2025
Table 89: Immunofluorescence Assay Historic Market Analysis in
China in US$ Thousand by Product: 2009-2017
Table 90: Chinese Immunofluorescence Assay Market by Product:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 91: Chinese Immunofluorescence Assay Market Growth
Prospects in US$ Thousand by Type for the Period 2018-2025
Table 92: Immunofluorescence Assay Historic Market Analysis in
China in US$ Thousand by Type: 2009-2017
Table 93: Chinese Immunofluorescence Assay Market by Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 94: Chinese Immunofluorescence Assay Market Growth
Prospects in US$ Thousand by Disease for the Period 2018-2025
Table 95: Immunofluorescence Assay Historic Market Analysis in
China in US$ Thousand by Disease: 2009-2017
Table 96: Chinese Immunofluorescence Assay Market by Disease:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 97: Chinese Demand for Immunofluorescence Assay in US$
Thousand by End-Use: 2018 to 2025
Table 98: Immunofluorescence Assay Market Review in China in
US$ Thousand by End-Use: 2009-2017
Table 99: Chinese Immunofluorescence Assay Market Share
Breakdown by End-Use: 2009 VS 2019 VS 2025
EUROPE
Market Facts & Figures
European Immunofluorescence Assay Market: Competitor Market
Share Scenario (in %) for 2019 & 2025
Table 100: European Immunofluorescence Assay Market Demand
Scenario in US$ Thousand by Region/Country: 2018-2025
Table 101: Immunofluorescence Assay Market in Europe: A
Historic Market Perspective in US$ Thousand by Region/Country
for the Period 2009-2017
Table 102: European Immunofluorescence Assay Market Share Shift
by Region/Country: 2009 VS 2019 VS 2025
Table 103: European Immunofluorescence Assay Market Estimates
and Forecasts in US$ Thousand by Product: 2018-2025
Table 104: Immunofluorescence Assay Market in Europe in US$
Thousand by Product: A Historic Review for the Period 2009-2017
Table 105: European Immunofluorescence Assay Market Share
Breakdown by Product: 2009 VS 2019 VS 2025
Table 106: European Immunofluorescence Assay Market Estimates
and Forecasts in US$ Thousand by Type: 2018-2025
Table 107: Immunofluorescence Assay Market in Europe in US$
Thousand by Type: A Historic Review for the Period 2009-2017
Table 108: European Immunofluorescence Assay Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 109: European Immunofluorescence Assay Market Estimates
and Forecasts in US$ Thousand by Disease: 2018-2025
Table 110: Immunofluorescence Assay Market in Europe in US$
Thousand by Disease: A Historic Review for the Period 2009-2017
Table 111: European Immunofluorescence Assay Market Share
Breakdown by Disease: 2009 VS 2019 VS 2025
Table 112: European Immunofluorescence Assay Addressable Market
Opportunity in US$ Thousand by End-Use: 2018-2025
Table 113: Immunofluorescence Assay Market in Europe:
Summarization of Historic Demand in US$ Thousand by End-Use for
the Period 2009-2017
Table 114: European Immunofluorescence Assay Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
FRANCE
Table 115: Immunofluorescence Assay Market in France by
Product: Estimates and Projections in US$ Thousand for the
Period 2018-2025
Table 116: French Immunofluorescence Assay Historic Market
Scenario in US$ Thousand by Product: 2009-2017
Table 117: French Immunofluorescence Assay Market Share
Analysis by Product: 2009 VS 2019 VS 2025
Table 118: Immunofluorescence Assay Market in France by Type:
Estimates and Projections in US$ Thousand for the Period
2018-2025
Table 119: French Immunofluorescence Assay Historic Market
Scenario in US$ Thousand by Type: 2009-2017
Table 120: French Immunofluorescence Assay Market Share
Analysis by Type: 2009 VS 2019 VS 2025
Table 121: Immunofluorescence Assay Market in France by
Disease: Estimates and Projections in US$ Thousand for the
Period 2018-2025
Table 122: French Immunofluorescence Assay Historic Market
Scenario in US$ Thousand by Disease: 2009-2017
Table 123: French Immunofluorescence Assay Market Share
Analysis by Disease: 2009 VS 2019 VS 2025
Table 124: Immunofluorescence Assay Quantitative Demand
Analysis in France in US$ Thousand by End-Use: 2018-2025
Table 125: French Immunofluorescence Assay Historic Market
Review in US$ Thousand by End-Use: 2009-2017
Table 126: French Immunofluorescence Assay Market Share
Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and
2025
GERMANY
Table 127: Immunofluorescence Assay Market in Germany: Recent
Past, Current and Future Analysis in US$ Thousand by Product
for the Period 2018-2025
Table 128: German Immunofluorescence Assay Historic Market
Analysis in US$ Thousand by Product: 2009-2017
Table 129: German Immunofluorescence Assay Market Share
Breakdown by Product: 2009 VS 2019 VS 2025
Table 130: Immunofluorescence Assay Market in Germany: Recent
Past, Current and Future Analysis in US$ Thousand by Type for
the Period 2018-2025
Table 131: German Immunofluorescence Assay Historic Market
Analysis in US$ Thousand by Type: 2009-2017
Table 132: German Immunofluorescence Assay Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 133: Immunofluorescence Assay Market in Germany: Recent
Past, Current and Future Analysis in US$ Thousand by Disease
for the Period 2018-2025
Table 134: German Immunofluorescence Assay Historic Market
Analysis in US$ Thousand by Disease: 2009-2017
Table 135: German Immunofluorescence Assay Market Share
Breakdown by Disease: 2009 VS 2019 VS 2025
Table 136: Immunofluorescence Assay Market in Germany: Annual
Sales Estimates and Forecasts in US$ Thousand by End-Use for
the Period 2018-2025
Table 137: German Immunofluorescence Assay Market in Retrospect
in US$ Thousand by End-Use: 2009-2017
Table 138: Immunofluorescence Assay Market Share Distribution
in Germany by End-Use: 2009 VS 2019 VS 2025
ITALY
Table 139: Italian Immunofluorescence Assay Market Growth
Prospects in US$ Thousand by Product for the Period 2018-2025
Table 140: Immunofluorescence Assay Historic Market Analysis in
Italy in US$ Thousand by Product: 2009-2017
Table 141: Italian Immunofluorescence Assay Market by Product:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 142: Italian Immunofluorescence Assay Market Growth
Prospects in US$ Thousand by Type for the Period 2018-2025
Table 143: Immunofluorescence Assay Historic Market Analysis in
Italy in US$ Thousand by Type: 2009-2017
Table 144: Italian Immunofluorescence Assay Market by Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 145: Italian Immunofluorescence Assay Market Growth
Prospects in US$ Thousand by Disease for the Period 2018-2025
Table 146: Immunofluorescence Assay Historic Market Analysis in
Italy in US$ Thousand by Disease: 2009-2017
Table 147: Italian Immunofluorescence Assay Market by Disease:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 148: Italian Demand for Immunofluorescence Assay in US$
Thousand by End-Use: 2018 to 2025
Table 149: Immunofluorescence Assay Market Review in Italy in
US$ Thousand by End-Use: 2009-2017
Table 150: Italian Immunofluorescence Assay Market Share
Breakdown by End-Use: 2009 VS 2019 VS 2025
UNITED KINGDOM
Table 151: United Kingdom Market for Immunofluorescence Assay:
Annual Sales Estimates and Projections in US$ Thousand by
Product for the Period 2018-2025
Table 152: Immunofluorescence Assay Market in the United
Kingdom: Historic Sales Analysis in US$ Thousand by Product for
the Period 2009-2017
Table 153: United Kingdom Immunofluorescence Assay Market Share
Analysis by Product: 2009 VS 2019 VS 2025
Table 154: United Kingdom Market for Immunofluorescence Assay:
Annual Sales Estimates and Projections in US$ Thousand by Type
for the Period 2018-2025
Table 155: Immunofluorescence Assay Market in the United
Kingdom: Historic Sales Analysis in US$ Thousand by Type for
the Period 2009-2017
Table 156: United Kingdom Immunofluorescence Assay Market Share
Analysis by Type: 2009 VS 2019 VS 2025
Table 157: United Kingdom Market for Immunofluorescence Assay:
Annual Sales Estimates and Projections in US$ Thousand by
Disease for the Period 2018-2025
Table 158: Immunofluorescence Assay Market in the United
Kingdom: Historic Sales Analysis in US$ Thousand by Disease for
the Period 2009-2017
Table 159: United Kingdom Immunofluorescence Assay Market Share
Analysis by Disease: 2009 VS 2019 VS 2025
Table 160: United Kingdom Demand Estimates and Forecasts for
Immunofluorescence Assay in US$ Thousand by End-Use: 2018 to
2025
Table 161: United Kingdom Immunofluorescence Assay Market in
US$ Thousand by End-Use: 2009-2017
Table 162: Immunofluorescence Assay Market Share Shift in the
United Kingdom by End-Use: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 163: Rest of Europe Immunofluorescence Assay Market
Estimates and Forecasts in US$ Thousand by Product: 2018-2025
Table 164: Immunofluorescence Assay Market in Rest of Europe in
US$ Thousand by Product: A Historic Review for the Period
2009-2017
Table 165: Rest of Europe Immunofluorescence Assay Market Share
Breakdown by Product: 2009 VS 2019 VS 2025
Table 166: Rest of Europe Immunofluorescence Assay Market
Estimates and Forecasts in US$ Thousand by Type: 2018-2025
Table 167: Immunofluorescence Assay Market in Rest of Europe in
US$ Thousand by Type: A Historic Review for the Period
2009-2017
Table 168: Rest of Europe Immunofluorescence Assay Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 169: Rest of Europe Immunofluorescence Assay Market
Estimates and Forecasts in US$ Thousand by Disease: 2018-2025
Table 170: Immunofluorescence Assay Market in Rest of Europe in
US$ Thousand by Disease: A Historic Review for the Period
2009-2017
Table 171: Rest of Europe Immunofluorescence Assay Market Share
Breakdown by Disease: 2009 VS 2019 VS 2025
Table 172: Rest of Europe Immunofluorescence Assay Addressable
Market Opportunity in US$ Thousand by End-Use: 2018-2025
Table 173: Immunofluorescence Assay Market in Rest of Europe:
Summarization of Historic Demand in US$ Thousand by End-Use for
the Period 2009-2017
Table 174: Rest of Europe Immunofluorescence Assay Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 175: Immunofluorescence Assay Market in Asia-Pacific by
Product: Estimates and Projections in US$ Thousand for the
Period 2018-2025
Table 176: Asia-Pacific Immunofluorescence Assay Historic
Market Scenario in US$ Thousand by Product: 2009-2017
Table 177: Asia-Pacific Immunofluorescence Assay Market Share
Analysis by Product: 2009 VS 2019 VS 2025
Table 178: Immunofluorescence Assay Market in Asia-Pacific by
Type: Estimates and Projections in US$ Thousand for the Period
2018-2025
Table 179: Asia-Pacific Immunofluorescence Assay Historic
Market Scenario in US$ Thousand by Type: 2009-2017
Table 180: Asia-Pacific Immunofluorescence Assay Market Share
Analysis by Type: 2009 VS 2019 VS 2025
Table 181: Immunofluorescence Assay Market in Asia-Pacific by
Disease: Estimates and Projections in US$ Thousand for the
Period 2018-2025
Table 182: Asia-Pacific Immunofluorescence Assay Historic
Market Scenario in US$ Thousand by Disease: 2009-2017
Table 183: Asia-Pacific Immunofluorescence Assay Market Share
Analysis by Disease: 2009 VS 2019 VS 2025
Table 184: Immunofluorescence Assay Quantitative Demand
Analysis in Asia-Pacific in US$ Thousand by End-Use: 2018-2025
Table 185: Asia-Pacific Immunofluorescence Assay Historic
Market Review in US$ Thousand by End-Use: 2009-2017
Table 186: Asia-Pacific Immunofluorescence Assay Market Share
Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and
2025
REST OF WORLD
Table 187: Rest of World Immunofluorescence Assay Market
Estimates and Forecasts in US$ Thousand by Product: 2018 to
2025
Table 188: Rest of World Immunofluorescence Assay Historic
Market Review by Product in US$ Thousand: 2009-2017
Table 189: Immunofluorescence Assay Market in Rest of World:
Percentage Share Breakdown of Sales by Product for 2009, 2019,
and 2025
Table 190: Rest of World Immunofluorescence Assay Market
Estimates and Forecasts in US$ Thousand by Type: 2018 to 2025
Table 191: Rest of World Immunofluorescence Assay Historic
Market Review by Type in US$ Thousand: 2009-2017
Table 192: Immunofluorescence Assay Market in Rest of World:
Percentage Share Breakdown of Sales by Type for 2009, 2019, and
2025
Table 193: Rest of World Immunofluorescence Assay Market
Estimates and Forecasts in US$ Thousand by Disease: 2018 to
2025
Table 194: Rest of World Immunofluorescence Assay Historic
Market Review by Disease in US$ Thousand: 2009-2017
Table 195: Immunofluorescence Assay Market in Rest of World:
Percentage Share Breakdown of Sales by Disease for 2009, 2019,
and 2025
Table 196: Rest of World Immunofluorescence Assay Market
Quantitative Demand Analysis in US$ Thousand by End-Use: 2018
to 2025
Table 197: Immunofluorescence Assay Market in Rest of World:
Summarization of Historic Demand Patterns in US$ Thousand by
End-Use for 2009-2017
Table 198: Rest of World Immunofluorescence Assay Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025

IV. COMPETITION

ABCAM PLC
BIO-RAD LABORATORIES
CELL SIGNALING TECHNOLOGY
DANAHER CORPORATION
INOVA DIAGNOSTICS
MEDIPAN GMBH
MILLIPORESIGMA
PERKINELMER
SINO BIOLOGICAL
THERMO FISHER SCIENTIFIC
VECTOR LABORATORIES, INC.

V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05798812/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.